Vita 34 AG Stock
Your prediction
Vita 34 AG Stock
Vita 34 AG shows a slight decrease today, losing €0.000 (-0.910%) compared to yesterday.
Criterium "Market Position" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vita 34 AG in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | -0.910% | 0.926% | -2.679% | 25.000% | 32.282% | -33.211% | -56.746% |
| Mediclin AG | 0.530% | 9.412% | 3.333% | 48.800% | 56.303% | 8.772% | -1.064% |
| M1 Kliniken AG | 0.110% | -3.871% | 25.035% | 10.370% | 7.387% | 182.911% | 93.926% |
| Addus Homecare Corp. | -1.040% | -6.373% | -2.051% | -14.732% | -20.417% | -3.046% | 10.405% |
News
EQS-News: FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
EQS-News: FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland
EQS-Adhoc: FamiCord AG: Polski Bank Komórek Macierzystych sp. z o. o. is to acquire 100 % in stem cell bank “nOvum” spółka z ograniczoną odpowiedzialnością, Warsaw, Poland
EQS-News: FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future
EQS-News: FamiCord AG significantly increases revenue and earnings in the first half of 2025 and shifts focus even more strongly to core business in the future